DE602006010702D1 - Homomorpholinoxazolidinone als antibakterielle mittel - Google Patents

Homomorpholinoxazolidinone als antibakterielle mittel

Info

Publication number
DE602006010702D1
DE602006010702D1 DE602006010702T DE602006010702T DE602006010702D1 DE 602006010702 D1 DE602006010702 D1 DE 602006010702D1 DE 602006010702 T DE602006010702 T DE 602006010702T DE 602006010702 T DE602006010702 T DE 602006010702T DE 602006010702 D1 DE602006010702 D1 DE 602006010702D1
Authority
DE
Germany
Prior art keywords
sup
sub
homomorpholinoxazolidinone
antibacterial agent
het
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006010702T
Other languages
German (de)
English (en)
Inventor
Vara Prasad Venkata Nagendra Josyula
Frederick Earl Boyer Jr
Ji-Young Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co LLC
Original Assignee
Pharmacia and Upjohn Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co LLC filed Critical Pharmacia and Upjohn Co LLC
Publication of DE602006010702D1 publication Critical patent/DE602006010702D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE602006010702T 2005-06-29 2006-06-20 Homomorpholinoxazolidinone als antibakterielle mittel Active DE602006010702D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69486205P 2005-06-29 2005-06-29
PCT/IB2006/001730 WO2007000644A1 (en) 2005-06-29 2006-06-20 Homomorpholine oxazolidinones as antibacterial agents

Publications (1)

Publication Number Publication Date
DE602006010702D1 true DE602006010702D1 (de) 2010-01-07

Family

ID=37101665

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006010702T Active DE602006010702D1 (de) 2005-06-29 2006-06-20 Homomorpholinoxazolidinone als antibakterielle mittel

Country Status (8)

Country Link
EP (1) EP1899331B1 (https=)
JP (1) JP2008544979A (https=)
AT (1) ATE449773T1 (https=)
CA (1) CA2610978A1 (https=)
DE (1) DE602006010702D1 (https=)
DK (1) DK1899331T3 (https=)
ES (1) ES2335307T3 (https=)
WO (1) WO2007000644A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080110877A (ko) 2006-03-31 2008-12-19 재단법인 이쯔우 연구소 헤테로환을 갖는 신규 화합물
US8178683B2 (en) 2007-08-06 2012-05-15 Micurx Pharmaceuticals, Inc. Antimicrobial ortho-fluorophenyl oxazolidinones for treatment of bacterial infections
WO2009044777A1 (ja) * 2007-10-02 2009-04-09 Research Foundation Itsuu Laboratory 7員ヘテロ環を有するオキサゾリジノン誘導体
CN105612166B (zh) 2014-02-21 2019-02-19 上海盟科药业有限公司 治疗用水溶性(o-羰基)氨基磷酸酯前药
EP3307268B1 (en) 2015-07-17 2021-09-01 The Global Alliance for TB Drug Development, Inc. Substituted phenyloxazolidinones for antimicrobial therapy

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK283420B6 (sk) 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
MY115155A (en) 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
BR9509673A (pt) 1994-11-15 1997-09-30 Upjohn Co Compostos e uso dos mesmos
BR9813985A (pt) 1997-11-12 2000-09-26 Upjohn Co Derivados de oxazolidinona e composições farmacêuticas
JP2000204084A (ja) 1998-11-11 2000-07-25 Hokuriku Seiyaku Co Ltd チオカルバミド酸誘導体
AU764980B2 (en) 1998-11-27 2003-09-04 Pharmacia & Upjohn Company Oxazolidinone antibacterial agents having a thiocarbonyl functionality
US6297242B1 (en) 1999-08-12 2001-10-02 Ortho-Mcneil Pharmaceutical, Inc. N-substituted amidine and guanidine oxazolidinone antibacterials and methods of use thereof
HUP0203869A2 (hu) 1999-12-21 2003-07-28 Pharmacia & Upjohn Co. Szulfoximin funkcionalitással rendelkező oxazolidinok és alkalmazásuk mikrobaellenes szerként, a vegyületeket tartalmazó gyógyszerkészítmények
AU2001253113B2 (en) 2000-04-20 2005-02-03 Pharmacia & Upjohn Company Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis
ES2245698T3 (es) 2000-06-30 2006-01-16 PHARMACIA & UPJOHN COMPANY LLC Composiciones para el tratamiento de infecciones bacterianas que contienen un compuesto de oxazolidinona, sulbactam y ampicilina.
GB0017225D0 (en) 2000-07-14 2000-08-30 Really Useful Products Limited Container
DE10034627A1 (de) 2000-07-17 2002-01-31 Bayer Ag Aryl-substituierte Oxazolidinone mit Cytokin inhibitorischer Wirkung
BR0112826A (pt) 2000-07-17 2003-06-24 Ranbaxy Lab Ltd Derivados da oxazolidinona como antimicrobianos
WO2002016960A1 (en) 2000-08-24 2002-02-28 Sirf Technology, Inc. Apparatus for reducing auto-correlation or cross-correlation in weak cdma signals
PE20020578A1 (es) 2000-10-10 2002-08-14 Upjohn Co Una composicion de antibiotico topico para el tratamiento de infecciones oculares
WO2002072066A1 (en) 2001-02-05 2002-09-19 Pharmacia & Upjohn Company Composition for rectal delivery of an oxazolidinone antibacterial drug
DE10105989A1 (de) 2001-02-09 2002-08-14 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
ES2268011T3 (es) 2001-04-07 2007-03-16 Astrazeneca Ab Oxazolidinonas que contienen un grupo sulfonimida como antibioticos.
GB0108793D0 (en) 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compounds
US6956040B2 (en) 2001-07-16 2005-10-18 Ranbaxy Laboratories Limited Oxazolidinone piperazinyl derivatives as potential antimicrobials
EP1409464A4 (en) 2001-07-16 2005-11-02 Ranbaxy Lab Ltd OXAZOLIDINONE DERIVATIVES AS POTENTIAL ANTIMICROBIALS
TW200302095A (en) 2002-01-25 2003-08-01 Upjohn Co Oxazolidinone cotherapy
BR0307898A (pt) 2002-02-22 2004-12-07 Pharmacia Corp Formulações de droga antibiótica oftálmica contendo um composto de ciclodextrina e cloreto de cetil piridìnio
EP1476135A1 (en) 2002-02-22 2004-11-17 Pharmacia Corporation Ophthalmic formulation with gum system
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
JP2005524661A (ja) 2002-02-28 2005-08-18 アストラゼネカ アクチボラグ 3−シクリル−5−(窒素含有5員環)メチル−オキサゾリジノン誘導体と抗菌剤としてのその使用
IL163643A0 (en) 2002-02-28 2005-12-18 Astrazeneca Ab Oxazolidinone derivatives, processes for their forpreparation, and pharmaceutical compositions containing them
BR0308806A (pt) 2002-03-29 2005-01-04 Upjohn Co Uso de oxazolidinonas para tratar infecções do tipo pé diabético
WO2003093247A2 (en) 2002-04-30 2003-11-13 Orchid Chemicals & Pharmaceuticals Ltd Antibacterial agents
TW200403240A (en) 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents
WO2004009587A1 (en) 2002-07-22 2004-01-29 Orchid Chemicals & Pharmaceuticals Ltd Oxazolidinone derivatives as antibacterial agents
MXPA05001199A (es) 2002-07-29 2005-05-16 Ranbaxy Lab Ltd Derivados de oxazolidinona como antimicrobianos.
EP1578734A1 (en) 2002-08-22 2005-09-28 Orchid Chemicals and Pharmaceuticals Ltd Novel antibacterial agents

Also Published As

Publication number Publication date
DK1899331T3 (da) 2010-03-08
CA2610978A1 (en) 2007-01-04
ES2335307T3 (es) 2010-03-24
ATE449773T1 (de) 2009-12-15
EP1899331A1 (en) 2008-03-19
EP1899331B1 (en) 2009-11-25
JP2008544979A (ja) 2008-12-11
WO2007000644A1 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
MEP8409A (en) Fused heterocyclic compound
NO20070532L (no) Substituerte 2-alkyl-kinazolinonderivater som PARP-inhibitorer
MEP61208A (en) Novel compounds having inhibitory activity against sodium-dependant transporter
EA200601830A1 (ru) Ортозамещённые арильные или гетероарильные амидные соединения
ATE454152T1 (de) 2-aminopyrimidin-derivate als raf-kinase-hemmer
AP1902A (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
WO2007016392A3 (en) Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
WO2005092895A3 (en) Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
NO20054224L (no) Nye 2-pyridinkarboksamidderivater
NO20023097L (no) Heterocykliske forbindelser med sulfonamidgrupper
WO2008114819A1 (ja) 新規アデニン化合物
ATE556058T1 (de) 1-(2h)-isochinolonderivat
ATE449099T1 (de) Derivate des 2-trifluormethyl-6-aminopurins als phosphodiesterase 4 inhibitoren
NO20053246L (no) Kondensert 1,3-dihydroimidazol-ringforbindelse.
ATE540928T1 (de) Isochinolinverbindungen und ihre medizinische verwendung
HRP20070430T3 (en) (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
ITMI20041566A1 (it) "trpv1 agonisti, formulazioni che li contengono e loro usi"
DE602006011752D1 (de) Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
CA2655527C (en) Cinnamoyl-piperazine derivatives and their use as par-1 antagonists
NO20072753L (no) 3-Etylidenhydrazinosubstituerte heterocykliske forbindelser som trombopoietinreseptoraktivatorer
ATE417841T1 (de) Furanderivate als ep4-rezeptorantagonisten
EP1961734A4 (en) AMINE CONNECTION AND ITS USE FOR MEDICAL PURPOSES
DK1447400T3 (da) Bicyklisk forbindelse
ATE519818T1 (de) Reversibel thermochrome zusammensetzung
DE602006010702D1 (de) Homomorpholinoxazolidinone als antibakterielle mittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition